| Hoda Ahmadi, MD | |
|
1311 S Lincoln St, Elkhorn, WI 53121-4375 | |
| (262) 723-4600 | |
| (262) 723-4710 |
| Full Name | Hoda Ahmadi |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 17 Years |
| Location | 1311 S Lincoln St, Elkhorn, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447459912 | NPI | - | NPPES |
| 1447459912 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 56317 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Memorial Hospital Burlington | Burlington, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Physicians And Surgeons Sc | 6608926084 | 5 |
News Archive
A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to more quickly and accurately assess a patient's need for an implantable cardiac defibrillator (ICD).
Thanks to powerful computational tools developed at Simon Fraser University, more than 100 scientists from around the world have genetically mapped the largest and most varied number of human genomes to date.
MAKO Surgical Corp. announced that its RIO® Robotic Arm Interactive Orthopedic System has received a 2010 Gold Medical Design Excellence Award. RIO® is used to perform MAKOplasty® partial knee resurfacing, a treatment option for patients with early to mid-stage osteoarthritis of the knee.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
› Verified 6 days ago
| Entity Name | The Medical College Of Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to more quickly and accurately assess a patient's need for an implantable cardiac defibrillator (ICD).
Thanks to powerful computational tools developed at Simon Fraser University, more than 100 scientists from around the world have genetically mapped the largest and most varied number of human genomes to date.
MAKO Surgical Corp. announced that its RIO® Robotic Arm Interactive Orthopedic System has received a 2010 Gold Medical Design Excellence Award. RIO® is used to perform MAKOplasty® partial knee resurfacing, a treatment option for patients with early to mid-stage osteoarthritis of the knee.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
› Verified 6 days ago
| Entity Name | Eye Physicians And Surgeons Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508949181 PECOS PAC ID: 6608926084 Enrollment ID: O20090604000628 |
News Archive
A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to more quickly and accurately assess a patient's need for an implantable cardiac defibrillator (ICD).
Thanks to powerful computational tools developed at Simon Fraser University, more than 100 scientists from around the world have genetically mapped the largest and most varied number of human genomes to date.
MAKO Surgical Corp. announced that its RIO® Robotic Arm Interactive Orthopedic System has received a 2010 Gold Medical Design Excellence Award. RIO® is used to perform MAKOplasty® partial knee resurfacing, a treatment option for patients with early to mid-stage osteoarthritis of the knee.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
› Verified 6 days ago
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to more quickly and accurately assess a patient's need for an implantable cardiac defibrillator (ICD).
Thanks to powerful computational tools developed at Simon Fraser University, more than 100 scientists from around the world have genetically mapped the largest and most varied number of human genomes to date.
MAKO Surgical Corp. announced that its RIO® Robotic Arm Interactive Orthopedic System has received a 2010 Gold Medical Design Excellence Award. RIO® is used to perform MAKOplasty® partial knee resurfacing, a treatment option for patients with early to mid-stage osteoarthritis of the knee.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hoda Ahmadi, MD 1311 S Lincoln St, Elkhorn, WI 53121-4375 Ph: (262) 723-4600 | Hoda Ahmadi, MD 1311 S Lincoln St, Elkhorn, WI 53121-4375 Ph: (262) 723-4600 |
News Archive
A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to more quickly and accurately assess a patient's need for an implantable cardiac defibrillator (ICD).
Thanks to powerful computational tools developed at Simon Fraser University, more than 100 scientists from around the world have genetically mapped the largest and most varied number of human genomes to date.
MAKO Surgical Corp. announced that its RIO® Robotic Arm Interactive Orthopedic System has received a 2010 Gold Medical Design Excellence Award. RIO® is used to perform MAKOplasty® partial knee resurfacing, a treatment option for patients with early to mid-stage osteoarthritis of the knee.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
› Verified 6 days ago
Nicholas W. Veith, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1311 South Lincoln Street, Elkhorn, WI 53121 Phone: 262-723-4600 Fax: 262-723-4710 | |
Dr. Matthew Alan Dahlgren, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1311 S Lincoln St, Elkhorn, WI 53121 Phone: 262-723-4600 Fax: 262-723-4710 | |
Dr. Daniel Solverson, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1311 S Lincoln St, Elkhorn, WI 53121 Phone: 262-723-4600 | |
Mr. Mark F Brower, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1311 S Lincoln St, Elkhorn, WI 53121 Phone: 262-723-4600 Fax: 262-947-4996 |